Table 5

Uroflowmetry and Ultrasound of Altis vs Solyx vs TVT Abbrevo.

Altis (n ​= ​60)

Solyx (n ​= ​44)

Abbrevo (n ​= ​93)

Intergroup comparison p-value

Data available Altis/Solyx/Abbrevo(n)

Uroflowa

MFR Preoperative, mean ​± ​SD

34.9 ​± ​15.2

29.2 ​± ​11.0

30.0 ​± ​13.1

0.206

37/23/25

PVR Preoperative, mean ​± ​SD

25.6 ​± ​25.2

26.5 ​± ​29.0

27.3 ​± ​28.8

0.912

37/23/24

MFR Postoperative, mean ​± ​SD

26.6 ​± ​14.2

28.2 ​± ​12.2

30.2 ​± ​10.1

0.541

37/23/25

PVR Postoperative, mean ​± ​SD

43.6 ​± ​37.4

39.4 ​± ​33.8

14.0 ​± ​16.2

0.002

37/23/24

MFR change, mean ​± ​SD

−8.3 ​± ​16.7

−1.0 ​± ​12.3

0.27 ​± ​15.5

0.064

37/23/25

PVR change, mean ​± ​SD

18.0 ​± ​41.9

12.8 ​± ​41.5

−13.3 ​± ​35.8

0.012

37/23/24

MFR change (intragroup preop vs postop)

0.005

0.701

0.931

37/23/25

PVR change (intragroup preop vs postop)

0.013

0.153

0.082

37/23/24

Symphisis-Sling distance

Sling distance at valsalva, mean ​± ​SD

13.8 ​± ​2.9

14.5 ​± ​2.9

13.8 ​± ​3.6

0.579

49/32/29

Sling distance at rest, mean ​± ​SD

15.7 ​± ​4.5

16.3 ​± ​3.7

15.9 ​± ​4.5

0.843

49/32/29

  • (n): number of cases; MFR: maximum flow rate; PVR: post void residual; assessment performed at uroflowmetry prior to consent for continence surgery Sling distance (mm).

  • Pairwise comparison, p-values (Bonferroni method); PVR postoperative, p ​= ​1.00 (Altis vs Solyx); p ​= ​0.002 (Altis vs Abbrevo); p ​= ​0.023 (Solyx vs Abbrevo), PVR change, p ​= ​1.00 (Altis vs Solyx); p ​= ​0.012 (Altis vs Abbrevo), p ​= ​0.086 (Solyx vs Abbrevo).

  • a Uroflow:included all cases with both pre or postop uroflow data available for comparison, excluded patients with voided volume <150 ​ml.